lobbying_activities: 2141639
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2141639 | 28cda5de-351a-42e6-9636-41c41d190dac | Q2 | ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES | 46131 | ENLISTED ASSOCIATION OF THE NATIONAL GUARD OF THE UNITED STATES | 2018 | second_quarter | DEF | S.1086 and H.R. 5121, bills to amend title 10, United States Code, to remove the prohibition on eligibility for TRICARE Reserve Select of members of the reserve components of the Armed Forces who are eligible to enroll in a health benefits plan under chapter 89 of title 5, United States Code; S. 2416 and H.R. 5038, Reserve Component Benefits Parity Act of 2018; H.R. 2810, authorizes FY18 appropriations and sets forth policies for the Department of Defense (DOD) programs and activities, including military personnel strengths. It does not provide budget authority, which is provided in subsequent appropriations legislation H.R. 4633, the Credentialing, Educating, and Relevant Training Initiative for Your Heroes (CERTIFY Heroes) Act. This bill would make a minor amendment to 10 USC 2006a to give people in DOD the ability to use their tuition assistance for any credentials, licenses, or certifications recognized by or necessary for practice in their state. FY19 Defense Direct Report Language. Rare Cancers. --- The disproportionate impact of rare cancers on veterans, the number of rare cancers affecting veterans that are understudied and misunderstood, and inadequate treatment options for rare cancers are concerning. Therefore, the Department is instructed to provide a report to the Committees within 90 days of enactment of this Act for each of the last five years: the prevalence rate of rare cancers among veterans; the types of treatments being provided to veterans specifically for rare cancers; any studies on rare cancers conducted by the Department; the Department's expenditures on the treatment of rare cancers; the Department's programs dedicated to addressing rare cancers among veterans; and recommendations on ways the Department can enhance rare cancer treatments for veterans. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019 | Defense, Dept of (DOD),Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 20000 | 0 | 0 | 2018-07-10T13:27:06.743000-04:00 |